Abzena Showcases Discovery and Developability Services at PEGS Europe 2019

Bespoke approach generates high affinity antibodies and selects lead candidates with the strongest chances of success in[...] Read more

Abzena Announces New Fully Integrated Developability and Optimization Service to Improve Lead Selection and De-risk Biologic Cell Line Development

Cambridge, UK 21 March 2019 – Abzena, the leading biologics target to GMP partner research organisation (PRO),[...] Read more

Babraham Bioscience Technologies “Technology Development Laboratory” (TDL) moves to Abzena

Cambridge, UK, 5 January 2018 – Abzena plc (AIM: ABZA, ‘Abzena’), the life sciences group providing services and[...] Read more

Interested in our services? Get In Touch